Back to Top Skip to main content

Army, FDA discuss 3D printing at workshop

When a medical device breaks down on a medical unit deployed to a remote part of the world, the closest repair parts could be thousands of miles away (U.S. Army photo by Francis S. Trachta) When a medical device breaks down on a medical unit deployed to a remote part of the world, the closest repair parts could be thousands of miles away (U.S. Army photo by Francis S. Trachta)

Recommended Content:

Military Hospitals and Clinics | Technology | Combat Support | Medical Logistics

FORT DETRICK, Md. — When a medical device breaks down on a U.S. Army unit deployed to a remote part of the world, the closest repair parts could be thousands of miles away.

Even when parts are readily available, the shipping process – sometimes into hostile environments – could take days or even weeks, if it’s logistically feasible at all.

As the Army embraces advanced manufacturing in its modernization strategies, medical logisticians are looking to 3D printing as a potential solution to this challenge.

"The medical industry is one of the fastest innovators in the defense industrial base, so the AMLC is used to working with industrial partners constantly pushing the state of the art,” said Jack Rosarius, director of Medical Maintenance Management Directorate within the U.S. Army Medical Materiel Agency, a direct reporting unit to Army Medical Logistics Command.

Specifically for medical devices, 3D printing technology – also known as additive manufacturing – may enable the Army to develop repair parts that extend the life cycle of equipment and ensure they are ready for use when and where Soldiers need them.

While the technology offers numerous new uses and potential advantages, it also poses regulatory challenges and warrants safety considerations still under review by the U.S. Food and Drug Administration.

On Dec. 9, 2019, AMLC hosted a military-specific workshop at Fort Detrick with FDA leaders on the topic to seek guidance on current policies, concept regulations and potential stumbling blocks as it explores manufacturing its own repair parts and other 3D-printed items.

Representatives from Army Materiel Command, Air Force and Defense Health Agency also took part in the discussion.

‘Really excited’

USAMMA started piloting additive manufacturing in 2015 in partnership with its equipment program managers. Rosarius said a heightened top-down focus from Army senior leadership has only helped to push the 3D printing movement forward.

“I’m really excited about the opportunities,” said USAMMA Commander Col. Timothy D. Walsh, who also serves as deputy commander of AMLC. “It’s an exciting time to be a part of Army medicine.”

The 3D printing process involves building a three-dimensional object using a computer-aided design model by adding material layer by layer, which is why it’s called additive manufacturing.

The process differs from conventional machining, casting or forging, in which material is removed from a stock item or poured into a mold and shaped to form a product.

Through 3D printing, medical devices can be produced using a range of media, including metals, plastics, hydrogels or even biological materials. Most printing systems do this by dividing or slicing a digital design file in two-dimensional layers, then building each layer on top of the previous layer.

According to the FDA, medical companies began embracing additive manufacturing to create devices that were previously impossible to make, personalized to the patient or both.

‘Gray areas’

While the technology has unlocked new production possibilities, it also has prompted the FDA to explore conceptual regulations to safeguard patients and institute performance requirements.

“The FDA is very focused on what the risk is and how to mitigate it” with 3D-printed medical products, said Matthew A. Di Prima, materials engineer for the agency.

Heather L. Agler, a senior program manager for the FDA, said the technology has created new “gray areas,” specifically when it comes to military production and uses.

Patient safety, however, remains the overarching issue under consideration by federal regulators.

Army’s commitment

During the workshop, AMLC officials gave an overview of the Army’s Advanced Manufacturing Directive and briefed the FDA on efforts to date.

USAMMA has made successful use of 3D printing to produce some obsolete repair parts already, like an impeller for a medical sink or a locking pin for a vaporizer used on an anesthesia machine.

Many more are in various stages of development or design.

“The Advanced Manufacturing Directive demonstrates the Army's commitment to getting this right, so we're positioned for multi-domain operations and large-scale combat operations,” Rosarius said. “The medical maintenance community is excited about expanding the ways we can support patient care downrange.”

Di Prima highlighted different additive manufacturing use-cases, in addition to current agency policy considerations for manufacturers.

The group also worked through different Army-specific scenarios to identify possible snags for ongoing or future efforts, as well as several action items for further discussion.

“We’re happy to participate,” Agler said. “The military is always thinking forward. It’s good to be able to learn … and very important that we continue to work together to make sure you have the right things available when they are needed.”

Disclaimer: Re-published content may be edited for length and clarity. Read original post.

You also may be interested in...

DHA IPM 18-017: Military Health System (MHS) Information Technology (IT) Investment Management Framework

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (v), establishes Defense Health Agency's (DHA) procedures to: .Establish the overarching guidance to implement policies and procedures for managing DHA Deputy Assistant Director, Information Operations (DAD IO)/J-6Defense Health Program (DHP) IT resources. The DHA Investment Management Framework is used as an enabler for MHS leadership to make informed transparent financial decisions associated with the DHA DAD IO/J-6 systems, services, and capabilities and will continue to be used in the foreseeable future.

  • Identification #: 18-017
  • Date: 11/7/2020
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA IPM 18-015: Cybersecurity Program Management

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the requirements of References (d) through (y): • Establishes the Defense Health Agency’s (DHA) procedures to implement and maintain a DHA Cybersecurity Program for the Military Health System (MHS) to protect and defend DHA information and Information Technology (IT). • Is effective immediately; it will be converted into DHA-Procedural Instruction (DHA-PI), “Cybersecurity Program Management.” This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-015
  • Date: 10/28/2020
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA IPM 18-007: Service Delivery Management Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (e): - Establishes the Defense Health Agency’s (DHA) procedures for implementing and managing high quality information technology (IT) services by the Chief Information Officer (CIO), Deputy Assistant Director Information Operations (DAD IO/J-6), Military Health System (MHS). The DHA Service Delivery Management program provides customers requesting IT services from the DAD IO/J-6 or Defense Information Systems Agency service catalogs with an on-demand, automated system that provides a single-entry point to submit service requests. The automated system enables DAD IO/J-6 to align business needs and use repeatable and scalable processes to holistically track, manage, and report on customer submitted requests for IT services from submission to fulfillment. - Is binding on DoD Components and supports the Director’s, DHA, responsibility to develop appropriate management models to maximize efficiencies in the activities carried out by the DHA. - This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction (DHA-PI). This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-007
  • Date: 7/28/2020
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA IPM 18-016: DHA IPM 18 016 Medical Coding of the DoD Health Records

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (s): • Establishes the Defense Health Agency’s (DHA) procedures for centralized oversight, standardized operations, and ensured quality and performance for the coding of DoD Health Records. • This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire 12 months from the date of issue.

DHA PI 6025.10: Change 1: Standard Processes, Guidelines, and Responsibilities of the DoD Patient Bill of Rights and Responsibilities in the Military Health System (MHS) Military Medical Treatment Facilities (MTFs)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (d), and in accordance with the guidance of References (e) through (t), establishes the Defense Health Agency’s (DHA) procedures to begin standard processes and guidelines for the Patient’s Bill of Rights and Responsibilities, Reference (e)), in MTFs.

Continuing Implementation of the Reform of the Military Health System

Policy

This memorandum directs the continued implementation of the Military Health System (MHS) organizational reform required by 10 U.S.C. § 1073c, and sections 71 land 712 of the John S. McCain National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2019. The DoD policy for this reform is guided by the goals of improved readiness, better health, better care, and lower cost. The Department will advance these objectives through specific organizational reforms directed by Congress and the continued direction of the Secretary of Defense·anct the National Defense Strategy.

DHA IPM 18-011: Video Network Center (VNC) Endpoint Standards

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (g): - Provides guidance for video network endpoint standards required for sites to connect to the Defense Health Agency (DHA) VNC network. These standards will help ensure security compliance, efficiency, and best practices are maintained across the DHA network. Meeting certification requirements brings many benefits, including: increased assurances of a successful video teleconference (VTC) experience, full access to bridge and point-to-point calls, and access to peer video networks, including the Department of Veterans Affairs, academia, and industry partners. Compliance with stated standards does not preclude users connecting to other DoD approved networks. - This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-011
  • Date: 9/20/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA IPM 18-013: Risk Management Framework (RMF)

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (ac): • Incorporates cybersecurity strategy, policy, awareness/training, assessment, continuous monitoring, authorization, implementation, and remediation. • Aligns with the Deputy Assistant Director, Information Operations (DAD IO) J-6/Chief Information Officer’s (CIO) key concept of increasing cybersecurity of Defense Health Agency’s (DHA) Information Technology (IT); therefore, robust risk assessment and management is required. • Encompasses lifecycle risk management to determine and manage the residual cybersecurity risk. • This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-013
  • Date: 9/20/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA PI 3201.05: Technology Transfer (T2) Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI) based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (t), establishes responsibilities, procedures, and guidance for the Defense Health Agency’s (DHA) T2 program.

  • Identification #: 3201.05
  • Date: 6/20/2019
  • Type: DHA Procedural Instruction
  • Topics: Technology

DHA IPM 18-018: Physical Custody and Control of the DoD Health Record

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): • Establishes the Defense Health Agency’s (DHA) procedures for the physical custody and control of DoD Health Records at all DoD Military Treatment Facilities (MTFs) and the management, monitoring, review, and evaluation of DoD Health Record availability at MTFs. • This DHA-IPM is effective immediately and will expire effective 12 months from the date of issue. It must be incorporated into the forthcoming DHA-Procedural Instruction, “Health Records Management”.

DHA IPM 18-017: Military Health System (MHS) Information Technology (IT) Investment Management Framework

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (v), establishes Defense Health Agency’s (DHA) procedures to: • Establish the overarching guidance to implement policies and procedures for managing DHA Deputy Assistant Director, Information Operations (DAD IO)/J-6 Defense Health Program (DHP) IT resources. The DHA Investment Management Framework is used as an enabler for MHS leadership to make informed transparent financial decisions associated with the DHA DAD IO/J-6 systems, services, and capabilities and will continue to be used in the foreseeable future. • Provide full and total awareness of all IT across the enterprise ensuring all MHS healthcare-related IT investments are accounted for and integrated both operationally and financially. This includes all IT systems, applications, and devices and all their funding identified to manage a coherent and integrated healthcare capability across the enterprise. • Provide and supersede guidance and instructions previously provided through the Services. As Military Medical Treatment Facilities (MTFs) transition to DHA management and responsibility, procedures in this DHA-IPM will supersede IT systems guidance and instructions previously provided through the Services; including IT systems in all MTFs, clinics, and enterprise services provided to Other Lines-of-Business (OLB), such as training and research, etc. In addition, it supports a coherent and comprehensive catalog of IT capability investments encompassing all IT used to support the MHS mission. • Require that all funding sources, type and Budget Activity Group (BAG), purchasing or supporting any IT must be identified for inclusion in the DHA portfolio of IT capability investments. • Provide superseding guidance and instruction, through this DHA-IPM until a DHA-Procedural Instruction is issued previously provided by the Services in References (w) through (ad), for the MTFs as they are transitioned to DHA management and responsibility. • This DHA-IPM is effective immediately and it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.

  • Identification #: 18-017
  • Date: 11/6/2018
  • Type: DHA Interim Procedures Memorandum
  • Topics: Technology

DHA PI 8140.01: Acceptable Use of Defense Health Agency Information Technology (IT) (Updated)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (m), establishes the Defense Health Agency’s (DHA) procedures for acceptable use of DHA IT by authorized and privileged users.

  • Identification #: DHA PI 8140.01
  • Date: 10/16/2018
  • Type: DHA Procedural Instruction
  • Topics: Technology

Implementing Congressional Direction for Reform of the Military Health System

Policy

Policy Memorandum, signed by Deputy Secretary of Defense Patrick M. Shanahan, to direct implementation of the Military Health System (MHS) organizational reform required by the National Defense Authorization Act.

Personal Protective Equipment Policy Guidance

Policy

This memorandum provides policy guidance to Department ofDefense (DoD) healthcare personnel (HCP) concerning how to more efficiently organize and stockpile personal protective equipment (PPE), and select protective clothing and equipment in response to infectious disease environments for direct patient care, contact with blood or body fluids, prolonged close interaction (less than three feet), and contact with deceased individuals.

DHA-PI 6025.03: Standard Processes and Criteria for Establishing Urgent Care (UC) Services and Expanded Hours and Appointment Availability in Primary Care in Medical Treatment Facilities (MTFs) to Support an Integrated Health Care System (IHCS)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (l), describes standard processes and criteria for the establishment of UC services and expanded hours and appointment availability in primary care in MTFs.

<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.